A new role for tamoxifen in oestrogen receptor-negative breast cancer when it is combined with epigallocatechin gallate

We have previously shown that tamoxifen+epigallocatechin gallate (EGCG) is synergistically cytotoxic towards oestrogen receptor (ER)-negative breast cancer cells. To determine if this response would correlate with significant tumour suppression in vivo, athymic nude female mice were implanted with M...

Descripción completa

Detalles Bibliográficos
Autores principales: Scandlyn, M J, Stuart, E C, Somers-Edgar, T J, Menzies, A R, Rosengren, R J
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2008
Materias:
Translational Therapeutics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2567064/
https://www.ncbi.nlm.nih.gov/pubmed/18797454
http://dx.doi.org/10.1038/sj.bjc.6604634

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2567064/
https://www.ncbi.nlm.nih.gov/pubmed/18797454
http://dx.doi.org/10.1038/sj.bjc.6604634

Ejemplares similares